IJMS | Free Full-Text | Low Dose Cyclophosphamide Modulates Tumor Microenvironment by TGF-β Signaling Pathway
Cyclophosphamide - wikidoc
Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer | npj Breast Cancer
Journal of Prescribing Practice - Dosing of mesna to avoid urothelial toxicity from cyclophosphamide infusion
Pazopanib and Oral Cyclophosphamide in Women With Platinum-Resistant or -Refractory Epithelial Ovarian Cancer | JCO Global Oncology
Dose and dose-intensity of epirubicin and cyclophosphamide | Download Table
A, the mechanisms by which low-dose cyclophosphamide inhibits the... | Download Scientific Diagram
PHARMA-Dosage calculations
Cyclophosphamide: Package Insert - Drugs.com
USE OF INTRAVENOUS CYCLOPHOSPHAMIDE IN VASCULITIS PATIENTS:
Frontiers | High-Dose Cyclophosphamide Administration Orchestrates Phenotypic and Functional Alterations of Immature Dendritic Cells and Regulates Th Cell Polarization
Pharmaceuticals | Free Full-Text | Pharmacokinetics and Pharmacogenetics of Cyclophosphamide in a Neonate and Infant Childhood Cancer Patient Population
Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor–Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00 | Journal of Clinical Oncology
Cyclophosphamide Injection: Package Insert - Drugs.com
Cyclophosphamide Concentrate Injection: PI - Drugs.com
Comparison of Dose Adjustment Strategies for Obesity in High-dose Cyclophosphamide Among Adult Hematopoietic Cell Transplantation Recipients: Pharmacokinetic Analysis - Transplantation and Cellular Therapy, Official Publication of the American Society ...
Dose-response curves for different effects of cyclophosphamide. Please... | Download Scientific Diagram
Practical Oncology Principles of Chemotherapy - ppt download
Cyclophosphamide - wikidoc
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial - The Lancet Oncology
Cyclophosphamide induced physiological and biochemical changes in mice with an emphasis on sensitivity analysis - ScienceDirect
High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy | British Journal of Cancer
Approved for use in:
Calculations of Doses
Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies | Bone Marrow Transplantation
